Corrigendum to ‘Safety of quadrivalent recombinant influenza vaccine in pregnant persons and their infants’ [AJOG Global Reports Volume 4, Issue 4, November 2024, 100395]

AJOG global reports Pub Date : 2025-06-17 DOI:10.1016/j.xagr.2025.100536

Amber Hsiao PhD, MPH , Arnold Yee MBA , Ruvim Izikson MD, MPH , Bruce Fireman MA , John Hansen MPH , Ned Lewis MPH , Sonja Gandhi-Banga PhD , Alexandre Selmani PhD , Oxana Talanova MD, MPH , Heidi Kabler MD , Ajinkya Inamdar MBBS, MS, MBA , Nicola P. Klein MD, PhD

引用次数: 0

查看原文本刊更多论文

“四价重组流感疫苗对孕妇及其婴儿的安全性”的更正[AJOG全球报告第4卷，第4期，2024年11月，100395]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

AJOG global reports Endocrinology, Diabetes and Metabolism, Obstetrics, Gynecology and Women's Health, Perinatology, Pediatrics and Child Health, Urology

CiteScore

1.20

自引率

0.00%

发文量